The differentiation of benign and malignant thyroid nodules.
Lubitz
Carrie C
CC
Department of Surgery, New York Presbyterian Hospital, USA.
Fahey
Thomas J
TJ
D044963:Biopsy, Fine-Needle; D015820:Cadherins / Q000378:metabolism; D002116:Calcitonin / Q000378:metabolism; D002291:Carcinoma, Papillary / Q000378:metabolism; D037502:Galectin 3 / Q000378:metabolism; D020869:Gene Expression Profiling; D007150:Immunohistochemistry; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism; D020411:Oligonucleotide Array Sequence Analysis; D047495:PPAR gamma / Q000378:metabolism; D051059:PTEN Phosphohydrolase / Q000378:metabolism; D048493:Proto-Oncogene Proteins B-raf / Q000378:metabolism; D019859:Proto-Oncogene Proteins c-met / Q000378:metabolism; D019098:Telomerase / Q000378:metabolism; D016606:Thyroid Nodule / Q000175:diagnosis* / Q000378:metabolism / Q000473:pathology; D018631:ras Proteins / Q000378:metabolism
D015820:Cadherins; D037502:Galectin 3; D047495:PPAR gamma; D002116:Calcitonin; D019859:Proto-Oncogene Proteins c-met; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf; D020928:Mitogen-Activated Protein Kinases; D019098:Telomerase; D051059:PTEN Phosphohydrolase; C494929:PTEN protein, human; D018631:ras Proteins